P. Schmid
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- CAR-T cell therapy research
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 4
- Cancer Treatment and Pharmacology 2
- Cancer Immunotherapy and Biomarkers 2
- HER2/EGFR in Cancer Research 2
- PARP inhibition in cancer therapy 1
- CAR-T cell therapy research 1
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Hope S. Rugo (2 shared papers)Sylvia Adams (1 shared paper)Hiroji Iwata (1 shared paper)Eric P. Winer (1 shared paper)Manika Kaul (1 shared paper)Andreas Schneeweiß (1 shared paper)Shilpen Patel (1 shared paper)Luciana Molinero (1 shared paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
P. Schmid
4 papers receiving 336 citations
Hit Papers
Peers
Comparison fields: 5 of 44
- Oncology 287
- Cancer Research 113
- Pulmonary and Respiratory Medicine 142
- Immunology 67
- Genetics 12
Countries citing papers authored by P. Schmid
This map shows the geographic impact of P. Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Schmid more than expected).
Fields of papers citing papers by P. Schmid
This network shows the impact of papers produced by P. Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Schmid. The network helps show where P. Schmid may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis Hit paper breakdown → | 2021 | 293 |
| 2 | 2022 | 42 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 |
About P. Schmid
P. Schmid is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Infectious Diseases and Organic Chemistry, having authored 4 papers that have together received 343 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Genomics and Diagnostics (1 paper), PARP inhibition in cancer therapy (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (287 citations), Cancer Research (113 citations), Pulmonary and Respiratory Medicine (142 citations), Immunology (67 citations) and Genetics (12 citations). P. Schmid has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Hope S. Rugo, Sylvia Adams, Hiroji Iwata, Eric P. Winer, Manika Kaul, Andreas Schneeweiß, Shilpen Patel, Luciana Molinero, Volkmar Henschel and Leisha A. Emens. Their work appears in journals such as Annals of Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.